Berlin-based Aignostics, a leader in AI-driven pathology solutions, has secured €31 million in an oversubscribed Series B round led by ATHOS and supported by Mayo Clinic, HTGF, Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and IBB Ventures. The funding brings Aignostics’ total raised capital to over €50 million.
